1. Home
  2. News
  3. Proteomics International Laboratories Ltd.
  4. Unique panel of biomarkers identified for oesophageal cancer
More Proteomics International Laboratories Ltd. news
Proteomics International Laboratories Ltd.ASX: PIQ

Unique panel of biomarkers identified for oesophageal cancer

Feb 3, 2022 at 9:41 PM EST · Issued by Proteomics International Laboratories Ltd.

Filed with ASX · Feb 3, 2022 at 9:41 PM EST · 10 pages · English

On 6ix: 6ix.com/news/unique-panel-of-biomarkers-identified-for-oesophageal-cancer

Proteomics International Laboratories Ltd. on 6ix

Earlier from Proteomics International Laboratories

  • December 2021 Quarterly Activities Report and Appendix 4CJan 26, 2022
  • Proteomics secures major pharmacokinetic testing contractDec 15, 2021
  • Proteomics receives $1.2 million in R&D tax incentiveDec 13, 2021
  • PromarkerD distribution network expands to BritainNov 22, 2021
  • PromarkerD outperforms standard of care tests for DKDNov 4, 2021

Later from Proteomics International Laboratories

  • PromarkerD completes pre-assessment for Medicare rebateFeb 21, 2022
  • New Clinical Advisory Board for PromarkerD global rolloutApr 12, 2022
  • March 2022 Quarterly Activities Report and Appendix 4CApr 27, 2022
  • Proteomics awarded $400,000 funding to support manufacturingMay 11, 2022
  • PromarkerD manufacturing tech-transfer completedJun 15, 2022
All Proteomics International Laboratories news releases↗

Follow Proteomics International Laboratories into a list and get an email when it puts out news.

Follow Proteomics International Laboratories
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer